Alyeska Investment Group, L.P. Palatin Technologies Inc Call Options Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$0.98 - $1.64 $276,360 - $462,480	-282,000 Reduced 60.55%	183,732 $0
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $976,184 - $1.56 Million	-1,072,730 Reduced 69.73%	465,732 $452,000
Q3 2017 Nov 14, 2017	BUY	$0.39 - $0.66 $600,000 - $1.02 Million	1,538,462	1,538,462 $1.02 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.